Patent details
EP1863940 Title: METHOD OF RISK MANAGEMENT FOR PATIENTS UNDERGOING NATALIZUMAB TREATMENT
Basic Information
- Publication number:
- EP1863940
- PCT Application Number:
- PCT/US/2006/006723
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP067697706
- PCT Publication Number:
- WO/2006/112951
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- METHOD OF RISK MANAGEMENT FOR PATIENTS UNDERGOING NATALIZUMAB TREATMENT
- French Title of Invention:
- MÉTHODE DE GESTION DES RISQUES CONCERNANT LES PATIENTS SOUMIS À UN TRAITEMENT À BASE DE NATALIZUMAB
- German Title of Invention:
- VERFAHREN ZUM RISIKOMANAGEMENT FÜR MIT NATALIZUMAB BEHANDELTEN PATIENTEN
- SPC Number:
Dates
- Filing date:
- 24/02/2006
- Grant date:
- 06/06/2012
- EP Publication Date:
- 06/06/2012
- PCT Publication Date:
- 26/10/2006
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 12/12/2007
- EP B1 Publication Date:
- 06/06/2012
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 24/02/2013
- Expiration date:
- 24/02/2026
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 24/02/2006
- Name:
- Seedlings Life Science Ventures LLC.
- Address:
- 770 Broadway 2nd Floor/power Space, New York, NY 10003, United States (US)
Inventor
1
- Name:
- RUBIN Keith H.
- Address:
- United States (US)
2
- Name:
- GLAZER Steven
- Address:
- United States (US)
Priority
- Priority Number:
- 658335 P
- Priority Date:
- 03/03/2005
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- C12Q 1/68;
| Filing date | Document type | Number of pages |
|---|